DNA Synthesis and Repair GenesRRM1andERCC1in Lung Cancer
Top Cited Papers
Open Access
- 22 February 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (8) , 800-808
- https://doi.org/10.1056/nejmoa065411
Abstract
RRM1, the regulatory subunit of ribonucleotide reductase, is involved in carcinogenesis, tumor progression, and the response of non–small-cell lung cancer to treatment.Keywords
This publication has 30 references indexed in Scilit:
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- RRM1 and PTEN As Prognostic Parameters for Overall and Disease-Free Survival in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- RRM1-induced metastasis suppression through PTEN-regulated pathwaysOncogene, 2003
- Prognostic Significance of Molecular Genetic Aberrations on Chromosome Segment 11p15.5 in Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Lung cancer and the human gene for ribonucleotide reductase subunit M1 (RRM1)Mammalian Genome, 1999
- Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.Proceedings of the National Academy of Sciences, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987